Press Release

Press Release
Mar
5
//
2024

London Research & Pharmaceuticals Presents

The advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

@ElasticThemes